Big names, big com­pa­nies back a cell ther­a­py start­up run by a high-pro­file re­gen­er­a­tive med ex­pert

One of the best known names in re­gen­er­a­tive med­i­cine is launch­ing a new biotech with as­sets and cash com­ing from a range of mar­quee com­pa­nies that in­cludes Cel­gene.

The founder of the War­ren, NJ-based up­start is Robert Hariri, a co-founder at Craig Ven­ter’s Hu­man Longevi­ty. Hariri ran An­thro­ge­n­e­sis when Cel­gene bought it out 15 years ago, then head­ed Cel­gene Cel­lu­lar Ther­a­peu­tics for a pe­ri­od. Along the way he de­vel­oped projects us­ing stem cells de­rived from hu­man pla­cen­tas and inked col­lab­o­ra­tions be­tween some of the key play­ers, in­clud­ing Cel­gene.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER